Medicus Sciences Acquisition announced today that due to its inability to complete a business combination within deadline, the board has elected to dissolve and liquidate the SPAC, effective Feb. 21. Shares are expected to end trading on the 17th.
The per-share redemption price is approximately $10.18.
The SPAC raised $92 million in a February 2021 IPO to focus on the medical technology sector, both in the United States and internationally. Read more.
